GlobeNewswire Inc.··Hagens BermanADMA Biologics Plunges 16% as Short Seller Alleges Channel Stuffing Scheme
ADMA Biologics shares crashed 16% after short seller accused the company of inflating revenues through improper rebates and extended payment terms to distributors.
ADMAsecurities fraudbiopharmaceutical